Regulations.gov document
Reunión pública sobre el desarrollo de medicamentos centrados en el paciente contra el…
Other · FDA-2023-N-0363 · posted Feb 23, 2023
Key facts
| Document ID | FDA-2023-N-0363-0003 |
|---|---|
| Title | Reunión pública sobre el desarrollo de medicamentos centrados en el paciente contra el COVID-19 persistente preguntas de debate |
| Document type | Other |
| Subtype | Report/Survey |
| Agency | FDA |
| Docket | FDA-2023-N-0363 |
| Posted | Feb 23, 2023 |
| Comment period opens | Feb 23, 2023 |
At a glance
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: